A new assessment of the Medicare Part D program based on a proposal from the West Health Policy Center finds that Medicare beneficiaries would save $29 billion if drug manufacturer rebates were used to reduce their out-of-pocket ...
Dec 19, 2019
0
1
Generic prescription drugs have saved the U.S. about US$1.7 trillion over the past decade. The Food and Drug Administration approved a record 781 new generics in 2018 alone, including generic versions of Cialis, Levitra ...
Dec 4, 2019
0
2
A new analysis of publicly reported financial data published today by researchers at West Health Policy Center and Johns Hopkins Bloomberg School of Public Health finds that large, brand-name drug manufacturers would still ...
Nov 14, 2019
1
1
The Drug Enforcement Administration was "slow to respond" as America grappled with a rising opioid epidemic, the Justice Department's inspector general said in a report Tuesday that faulted the agency for cutting back use ...
Oct 1, 2019
0
0
U.S. health officials said Friday they are investigating low levels of a potentially dangerous contaminant in the popular heartburn medication Zantac and related generic drugs.
Sep 13, 2019
0
1
Demand for prescription medications in the U.S. is at an all time high, given that 50% of adults have at least one chronic condition, and 25% have two or more. Sixty percent of the population, and 90% of Medicare beneficiaries ...
Sep 11, 2019
0
2
Dupixent (dupilumab) has been approved to treat nasal polyps in adults with chronic rhinosinusitis, the U.S. Food and Drug Administration announced today.
Jun 27, 2019
0
0
Canada's most populous province of Ontario on Monday announced plans to sue opioid makers to recover health care costs related to the deadly addiction epidemic.
May 27, 2019
0
5
Erenumab was the first drug of a new drug class for the prophylaxis of migraine to enter the German market in November 2018. In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) ...
Feb 7, 2019
0
1
Squamous cell carcinoma is one of the most common cancers of the skin and mucosa. Treatment options for the advanced stage have been very limited for patients with tumours of the head and neck, i.e. in the mouth, the pharynx ...
Jan 17, 2019
0
0
